Categories Multiple Myeloma

Zacks: Brokerages Expect BeiGene, Ltd. (NASDAQ:BGNE) Will Post Earnings of -$3.47 Per Share

Zacks: Brokerages Expect BeiGene, Ltd. (NASDAQ:BGNE) Will Post Earnings of -$3.47 Per Share Analysts predict that BeiGene, Ltd. (NASDAQ:BGNE) will announce earnings per share (EPS) of ($3.47) for the current quarter, Zacks reports. Two analysts have made estimates for BeiGene’s earnings. The lowest EPS estimate is ($4.77) and the highest is ($1.04). BeiGene reported earnings […]

Read More
Categories Multiple Myeloma

Highlighting Resiliency During Multiple Myeloma Awareness Month 2021

Highlighting Resiliency During Multiple Myeloma Awareness Month 2021 Multiple myeloma is not easily diagnosed, and its early symptoms may be confused for another condition. Each March, Multiple Myeloma Awareness Month puts multiple myeloma (MM) in the spotlight. A rare cancer, MM is not easily diagnosed early on, but it is the second most common blood […]

Read More
Categories Cancer

Oncology Professionals Look Back and Ahead at Cancer Care After A Year of COVID-19

Oncology Professionals Look Back and Ahead at Cancer Care After A Year of COVID-19 Reflecting on the impact of the COVID-19 pandemic, a panel of oncology professionals at the Association of Community Cancer Centers’ (ACCC) 47th Annual Meeting and Cancer Center Business Summit discussed the permanent paradigm shifts in oncology and how they responded, and […]

Read More
Categories Cancer

University of Glasgow: EUROPEAN CONSORTIUM TO USE AI TO IMPROVE PANCREATIC …

University of Glasgow: EUROPEAN CONSORTIUM TO USE AI TO IMPROVE PANCREATIC … University of Glasgow: EUROPEAN CONSORTIUM TO USE AI TO IMPROVE PANCREATIC CANCER TREATMENT – India Education,Education News India,Education News | India Education Diary Home Academics University of Glasgow: EUROPEAN CONSORTIUM TO USE AI TO IMPROVE PANCREATIC CANCER TREATMENT Published at Fri, 12 Mar […]

Read More
Categories Cancer

BiTE-ing into prostate cancer with bispecific T cell engagers

BiTE-ing into prostate cancer with bispecific T cell engagers Abstract Targeting prostate-specific membrane antigen (PSMA) has important therapeutic ramifications, more recently including immune oncology. Data were recently presented on the preclinical efficacy of a half-life extended bispecific T cell engager, AMG 160, which binds PSMA and CD3 to induce T cell-driven cytolytic activity against prostate […]

Read More
Categories Cancer

A New Way to Fund the Cancer Fight

A New Way to Fund the Cancer Fight Dr. Mona Jhaveri, Founder and Director of Music Beats Cancer, started her career as a cancer researcher and moved into the biotech industry where she quickly realized that fundraising is extremely difficult, if not impossible over time. After receiving her doctoral degree in biochemistry, she went on […]

Read More
Categories Uncategorized

Health is wealth with Johnson & Johnson

Health is wealth with Johnson & Johnson Evolved over 135 years into a leader in pharma, consumer health and medical devices Over a tenth of revenues invested in R&D every year IC TIP: Buy at $153.07 Tip style Growth Risk rating Medium Timescale Long Term Bull points Diversified growth across three distinct businesses Strong sales and earnings […]

Read More